ReviewInternational journal of clinical and experimental medicine2015

Sorafenib in combination with low-dose-homoharringtonine as a salvage therapy in primary refractory FLT3-ITD-positive AML: a case report and review of literature.

Gaixiang Xu et al.PubMed ↗Full text ↗

No numbers read from the abstract.